Antibacterial and Antimycotic Activity of Epilobium angustifolium L. Extracts: A Review
- PMID: 37895890
- PMCID: PMC10609845
- DOI: 10.3390/ph16101419
Antibacterial and Antimycotic Activity of Epilobium angustifolium L. Extracts: A Review
Abstract
The aim of this work was to provide an overview of available information on the antibacterial and antifungal properties of Epilobium angustifolium extracts. A literature search of Scopus, PubMed/Medline, and Google Scholar for peer-reviewed articles published between January 2000 and June 2023 was undertaken. A total of 23 studies were eligible for inclusion in this review. Significant variation of antimicrobial activity depending on the tested species and strains, type of extract solvent, or plant organs utilized for the extract preparation was found. E. angustifolium extracts were active against both Gram-positive and Gram-negative bacteria and showed antimycotic effects against the fungi of Microsporum canis and Trichophyton tonsurans and the dermatophytes Arthroderma spp. Greater susceptibility of Gram-positive than Gram-negative bacteria to fireweed extracts was found. A strong antibacterial effect was recorded for Staphylococcus aureus, Bacillus cereus, Micrococcus luteus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii including multi-drug resistant strains. E. angustifolium extract might find practical application as an antimicrobial in wound healing, components of cosmetic products for human and animals, or as food preservatives.
Keywords: Chamerion angustifolium; antibacterial activity; antifungal activity; fireweed; minimum inhibitory concentration (MIC); willowherb.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Efficacy of Willow Herb (Epilobium angustifolium L. and E. parviflorum Schreb.) Crude and Purified Extracts and Oenothein B Against Prostatic Pathogens.Antibiotics (Basel). 2025 Jan 23;14(2):117. doi: 10.3390/antibiotics14020117. Antibiotics (Basel). 2025. PMID: 40001361 Free PMC article.
-
Phenolic Content and Antimicrobial and Anti-Inflammatory Effects of Solidago virga-aurea, Phyllanthus niruri, Epilobium angustifolium, Peumus boldus, and Ononis spinosa Extracts.Antibiotics (Basel). 2020 Nov 6;9(11):783. doi: 10.3390/antibiotics9110783. Antibiotics (Basel). 2020. PMID: 33172081 Free PMC article.
-
Antimicrobial activity of Willowherb (Epilobium angustifolium L.) leaves and flowers.Curr Drug Targets. 2013 Aug;14(9):986-91. doi: 10.2174/13894501113149990177. Curr Drug Targets. 2013. PMID: 23796429
-
Camel urine as a potential source of bioactive molecules showing their efficacy against pathogens: A systematic review.Saudi J Biol Sci. 2024 May;31(5):103966. doi: 10.1016/j.sjbs.2024.103966. Epub 2024 Feb 25. Saudi J Biol Sci. 2024. PMID: 38495380 Free PMC article. Review.
-
Therapeutic Potential of Polyphenols from Epilobium Angustifolium (Fireweed).Phytother Res. 2016 Aug;30(8):1287-97. doi: 10.1002/ptr.5648. Epub 2016 May 24. Phytother Res. 2016. PMID: 27215200 Free PMC article. Review.
Cited by
-
Efficacy of Willow Herb (Epilobium angustifolium L. and E. parviflorum Schreb.) Crude and Purified Extracts and Oenothein B Against Prostatic Pathogens.Antibiotics (Basel). 2025 Jan 23;14(2):117. doi: 10.3390/antibiotics14020117. Antibiotics (Basel). 2025. PMID: 40001361 Free PMC article.
-
Exploring the Phytochemical Profile and Biological Insights of Epilobium angustifolium L. Herb.Plants (Basel). 2025 Jan 31;14(3):415. doi: 10.3390/plants14030415. Plants (Basel). 2025. PMID: 39942977 Free PMC article.
-
The Involvement of Epilobium parviflorum in Different Human Diseases, with Particular Attention to Its Antioxidant and Anti-Inflammatory Properties and Benefits to Vascular Health.Nutrients. 2025 May 3;17(9):1577. doi: 10.3390/nu17091577. Nutrients. 2025. PMID: 40362886 Free PMC article. Review.
References
-
- Arrigoni R., Ballini A., Topi S., Bottalico L., Jirillo E., Santacroce L. Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial Agents. Antibiotics. 2022;11:1431. doi: 10.3390/antibiotics11101431. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous